I'm just so happy a journal actually published a negative result.
--- CONFLICT OF INTERESTS HdW has served as scientific advisor to Schedule | Therapeutics, Gilgamesh Pharmaceuticals and Awakn Life Sciences, and she serves on the Board of Directors of PharmAla. None of these are directly related to this study. The other authors declare no conflicts of interest. ---
HdW being Harriet de Wit, the lead on the study.
Who sits on the Board of Directors of PharmAla [1].
PharmAla according to their website manufacture clinical-grade MDMA and novel (_patentable_) MDXX compounds for the scientific research community.
Compounds that it could easily be argued are threatened by LSD for therapeutic purposes.
...I wonder why the original PsyPost article doesn't mention this.